Expression of GATA-3 During Lymphocyte Differentiation and Mouse Embryogenesis by Oosterwegel, Mariëtte et al.
Developmental Immunology, 1992, Vol. 3, pp. 1-11
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 1992 Harwood Academic Publishers GmbH
Printed in the United States of America
Expression of GATA-3 During Lymphocyte
Differentiation and Mouse Embryogenesis
MARITTE OOSTERWEGEL, JANNEKE TIMMERMAN, JEFFREY LEIDEN, and HANS CLEVERS*
"tDepartment ofImmunology, University Hospital, Utrecht, The Netherlands
:Departments ofMedicine and Pathology, University of Chicago, Chicago, Illinois
The GATA family of C4 zinc-finger transcription factors has been implicated in tissue-
specific gene regulation in birds and mammals. One of the members of this family,
GATA-3, is reportedly expressed specifically in the T-cell lineage, where it interacts with
GATA motifs in the TCR-c, TCR-]/, and TCR- enhancers, thereby controlling the T-cell
phenotype. To evaluate the differentiation control properties of GATA-3, we have now
documented its expression pattern during lymphoid differentiation and murine
embryogenesis.
The onset of GATA-3 expression in the lymphoid lineage was studied in a panel of
lymphoid (precursor) cell lines by Northern blot analysis. GATA-3 was uniquely
expressed in T-lineage lymphocytes expressing TCR and CD3 genes; it was absent from
TCR/CD3 mRNA-negative prothymocytes and from all B-lineage cells.
In order to obtain information on the expression of GATA-3 outside the immune
system, in situ hybridization was performed on mouse embryos on day 11.5-14.5 of
gestation. GATA-3 mRNA was detected in fetal thymus and in erythroid cells. Outside
the haemopoietic system, we detected GATA-3 mRNA throughout the central nervous
system, in kidney, in the epidermis, lens fibers, the inner ear, whisker follicles, and in
the primary palate.
These data provide new clues about the potential role of GATA-3 during mouse
development, and will aid the interpretation of currently ongoing gene knockout
experiments.
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INTRODUCTION
Mature T and B lymphocytes are thought to arise
from pluripotent stem cells through a common
lymphoid progenitor and several discrete precur-
sor B- and T-cell stages. Each step in this differ-
entiation pathway is characterized by specific
changes in cellular phenotype, which in turn is
determined .by the complement of actively tran-
scribed structural genes. Control of the
expression of such sets of genes is exerted by
developmentally active transcription factors. The
regulated activity of these transcription factors is
believed to be central to the control of phenotype
during differentiation (Maniatis et al., 1987;
Atchinson, 1988; Johnson and McKnight, 1989).
*Corresponding author.
One family of transcription factors implicated
in tissue-specific gene regulation is the GATA
family. All GATA proteins recognize the GATA
consensus sequence and contain a C4 zinc-finger
motif. GATA-3, one of the members of this
family, is a candidate control gene implied to be
involved in T-cell differentiation (Ho et al., 1991;
Ko et al., 1991; Marine and Winoto, 1991). The
prototypic factor of this family, GATA-1
(previously termed GF-1, EryF1, or NF-E1), was
originally cloned from murine erythroid cells,
based on its affinity for the GATA motif in the /
globin gene (Tsai et al., 1989). Its expression was
then analyzed in detail and was observed to be
restricted to cells of the erythroid lineage, mast
cells and megakaryocytes (Martin et al., 1990).
Subsequently, three homologous genes (NF-Ela,
NF-Elb, and NF-Elc, renamed GATA-1, GATA-
2, and GATA-3) were cloned from chicken2 M. OOSTERWEGEL et al.
erythrocytes under low-stringency conditions,
using the murine GATA-1 cDNA (Yamamoto et
al., 1990). Based on homology, cDNA clones
encoding human GATA-1, -2, and -3 and murine
GATA-3 have since been isolated (Zon et al.,
1990; Ho et al., 1991; Ko et al., 1991; Marine and
Winoto, 1991; Dorfman et al., 1992). All three
proteins have been demonstrated to transactivate
transcription from a minimal TATA-box pro-
moter adjacent to a multimerized GATA motif
(Ho et al., 1991; Marine and Winoto, 1991; Dorf-
man et al., 1992).
The expression pattern of the three chicken
GATA genes has been studied by Northern
analysis. GATA-3, the subject of the present
study, is thus reportedly expressed in chicken
erythroid cells, T-lineage cells, fetal brain and
adult kidney (Yamamoto et al., 1990). Similar
studies performed in human and mouse so far
indicate that GATA-3 expression is restricted to
T-lineage lymphocytes (Ho et al., 1991; Ko et al.,
1991; Marine and Winoto, 1991). In line with this
observation, functional GATA motifs have been
detected in the T-cell-specific enhancers of the
TCR-o, -]/, and genes (Ho et al., 1991; Ko et al.,
1991; Marine and Winoto, 1991).
In order to evaluate the possible differen-
tiational control properties of GATA-3, we have
now analyzed in detail the onset of GATA-3
expression during murine lymphocyte differen-
tiation. To that end, Northern analysis was per-
formed on a panel of well-defined lymphoid
(precursor) cell lines. We arbitrarily distinguish
three different phenotypical stages in early T-cell
development with regard to rearrangement and
expression of the genes encoding the constituent
chains of the TCR/CD3 complex. Prothymocytes
express Thyl and CD2. They do not express TCR
or CD3 genes other than CD3-?’and have under-
gone no TCR gene rearrangements. Prethymo-
cytes express all CD3 chains as well as partially
rearranged TCR chains. Thymocytes/T cells have
fully rearranged TCR genes, and carry TCR/CD3
complexes on the cell surface. CD4 and CD8 first
appear on TCR/CD3-surface-positive thymo-
cytes. Corresponding stages have been defined in
the B-cell lineage (Alt et al., 1981).
As chicken GATA-3 was found expressed out-
side the immune system, and as we have
observed by Northern analysis that high
expression of GATA-3 occurs in the murine kid-
ney (J. Leiden, unpublished), we decided to
extend our study by in situ hybridization analy-
ses during murine embryogenesis.
RESULTS
In order to determine the onset of GATA-3
expression in the T-cell lineage, Northern analy-
sis was performed on a panel of precursor and
mature lymphoid cell lines. To that end, RNA
was isolated from a panel of murine prothymo-
cytes, prethymocytes, and thymocytes/T cells,
pro-B, pre-B, and mature B cells and control
fibroblast cell lines. The prothymocyte and pre-
thymocyte cell lines will be described in detail
elsewhere (A. Kruisbeek, in preparation). Briefly,
prothymocytes express Thyl, CD2, and CD3-
whereas no CD3-, CD3-e, TCRo, TCR-//, CD4, or
CD8 mRNA is present yet. All other T-cell lines
transcribe the genes encoding the constituent
chains of the TCR/CD3-complex (see also
Materials and Methods).
As shown in Fig. 1D, GATA-3 was abundantly
expressed in prethymocytes and thymocytes/T
cells. No GATA-3 was detectable in prothymo-
cytes, B-lineage cells, or fibroblasts. CD3-e and
TCR-c expression coincided with that of GATA-3
(Figs. 1B and 1C); CD3-’was already expressed
by the prothymocyte cell lines, indicative of their
T-lineage origin. Remarkably, CD3-?’mRNA was
also found in the myeloma cell lines Ag8 and Nsl
(Fig. 1A).
We next studied expression of GATA-3 by in
situ hybridization of murine embryos. Sections of
day 11.5, 12.5, and 14.5 embryos were hybridized
with a 3’ untranslated antisense RNA probe
under high stringency conditions. Figure 2
depicts a typical experiment using the GATA-3
probe on a midsagittal section of a day 14.5
embryo. Most sites of expression are visible on
the whole-embryo section. In what follows, we
discuss the expression of GATA-3 per individual
organ system, illustrated by higher-magnifi-
cation pictures where appropriate.
Thymus
On day 12.5, when the thymus was first visible,
GATA-3 mRNA could be detected in this organ
(Fig. 3A). A moderate level of GATA-3 mRNA
was also apaprent at day 14.5 (Fig. 2). Most
likely, thymocytes were responsible for theEXPRESSION OF GATA-3 3
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FIGURE 1. Northern blot analysis of CD3- CD3-G TCR-cz, and GATA-3 in a panel of lymphoid (progenitor) cells. Northern
blots were probed for (A) CD3- (B) CD3-e, (C) TCR-cz, and (D) GATA-3. Ticks mark the ribosomal bands. Equal amounts of
RNA were analyzed, as is evident from (E) the ethidium bromide-stained nitrocellulose blot: (1) 34.1.E and (3) 35.1.E are day 14
fetal thymus-derived prothymocyte cell lines; (2) 34.1.L and (4) 35.1.L are day 14 fetal thymus-derived prethymocyte cell lines; (5)
A1 and (6) B2 are day 17 fetal thyrrius-derived T cell lines; (7) EL-4 and (8) BS5147 are mature TCR-ob T-cell lines; (9) 38B9 is a
pro-B-cell line; (10) 40E1 and (11) 1881 are pre-B-cell lines; (12) Ag8 and (13) Nsl are myeloma-derived B-cell lines; (14) NIH-3T3,
(15) L cells and (16) 3T6 are fibroblast cell lines.4 M. OOSTERWEGEL et al.
observed GATA-3 signal. However, it could not
be excluded that thymic epithelium or other
structural elements in this organ also expressed
GATA-3.
Erythroid Lineage Cells
The lumina of arteries and veins were strongly
positive for GATA-3 (Figs. 2 and 3B). We inter-
preted this observation as expression in erythroid
cells, abundantly present in these blood vessels.
Consistent with this observation, the fetal liver
(Figs. 2 and 4), the major site of fetal erythro-
poiesis, and the heart (Fig. 3A) also expressed
GATA-3.
Kidney
At all days tested, prominent expression was
observed in kidney. Expression was first detected
FIGURE 2. In situ hybridization for GATA-3 on midsagittal sections of day 14.5 murine embryos. Data presented here represent
examples of multiple in situ experiments on serial sections of independent embryos. Bright field (left) and the accompanying dark
field (right) pictures are shown. GATA-3 was observed in the collecting tubules of the kdiney (=K) and in the medulla of the
adrenal gland (=A); in the thymus (=T) and the fetal liver (=FL); in dorsal blood vessels (=V); in the central nervous system, in the
diencephalon (=D), mesencephalon (=Me), the metencephalon-derived pons (=Po), and in the spinal cord (=SC); in the epidermis
(=S), whisker follicles (=W), and in the mesenchymal cells that form the periorbital region (=O).EXPRESSION OF GATA-3 5
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FIGURE 3. GATA-3 expression in thymus and in erythroid cells. In the haemopoietic system, GATA-3 was expressed in T cells
and in cells of the erythroid lineage. (A) At day 12.5, the thymus (=T) and erythroid cells in the heart (=H) contained GATA-3
mRNA. (B) GATA-3 was detected in erythroid cells in blood vessels (=V). In addition, cochlear epithelial cells of the inner ear (=
E) expressed GATA-3.6 M. OOSTERWEGEL et al.
in the mesonephric duct (day 11.5, not shown)
and was strictly localized in the collecting tubuli
at later stages (Fig. 4). These observations con-
firmed Northern blot experiments performed on
adult kidney (J. Leiden, unpublished).
Adrenal Gland
GATA-3 mRNA was detected at significant levels
in the neural crest-derived medulla of the adre-
nal gland. No GATA-3 was detectable in the
cortex of this endocrine organ, which is of meso-
dermal origin (Fig. 4).
Central Nervous System
High-level expression of GATA-3 was observed
throughout the brain and the spinal cord at all
days examined. At day 11.5, exclusive expression
was detected at the ventro-lateral site of the neu-
ral tube (not shown). At day 14.5, large areas of
the diencephalon, the mesencephalon, and the
pons in the metencephalon were positive, as was
the ventral site of the spinal cord (Fig. 2).
Epidermis and Skin-Derived Sensory Organs
Expression of GATA-3 in the epidermis was
observed at all days, but increased during ges-
tation (Figs. 2 and 5). At day 11.5, lens fibers con-
tained GATA-3 mRNA (Fig. 5A). This signal
became undetectable at later stages. At day 12.5,
mesenchymal cells of the periorbital region
started expressing GATA-3 and still did at day
14.5 (Figs. 2, 5B, and 5C). At day 12.5 and 14.5,
whisker follicles (Figs. 5B and 5C), representing
invaginated skin, and cochlear epithelial cells of
the inner ear (Fig. 3B) expressed high levels of
GATA-3 mRNA.
Palate
On day 12.5, the primary palate expressed high
levels of GATA-3. At this stage, endochondral
ossification initiates and the palate closes (Fig. 6).
DISCUSSION
The present report describes the expression of
GATA-3 during lymphocyte differentiation and
murine embryogenesis. In a panel of lymphoid
(precursor) cell lines, GATA-3 expression was
found restricted to the T-cell lineage and corre-
sponded with the onset of expression of the tar-
get genes TCR-o and TCR-]/. These observations
are consistent with the proposed regulatory role
of GATA-3 in T-cell differentiation. An
additional argument for such a function is the
conservation between chicken, mouse, and man
of GATA-3 sequence and expression in T cells
(Ko et al., 1991). Gene knockout experiments
FIGURE 4. Expression of GATA-3 in kidney and adrenal gland. At day 14.5, high-level expression of GATA-3 was observed in
the collecting tubules of the kidney (=K) and in the medulla of the adrenal gland (=A). Fetal liver (=FL) was also positive, most
likely due to the abundant presence of erythroid precursor cells.EXPRESSION OF GATA-3 7
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FIGURE 5. Expression of GATA-3 in epidermis and sensory organs derived from invaginated skin. At day 11.5, GATA-3 mRNA
was present in lens fibers (=L). Mesenchymal cells that form the perioribital region (=O) expressed GATA-3 at all days. Pigment
cells in the retina (=P) provide a nonspecific signal in dark field microscopy. From day 12.5, epidermis (=S) and whisker follicles
(=W) expressed GATA-3. (A) Day 11.5, (B) day 12.5, and (C) day 14.5
FIGURE 6. GATA-3 expression in palate. At day 12.5 of gestation, GATA-3 mRNA was detected in the primary palate (=Pa). N=
nasal fold, To=tongue, and Ma=mandible.
have demonstrated that the closely related
GATA-1 gene is essential for normal erythroid
differentiation (Pevny et al., 1981). It is tempting
to speculate that GATA-3 is equally important
for the T-cell lineage.
In situ hybridization of sections of murine
embryos at days 11.5, 12.5, and 14.5 revealed
multiple sites of GATA-3 expression during
ontogeny. No common denominator was appar-
ent for the ontogenic origin of the various cell
types transcribing the GATA-3 gene. GATA-3
mRNA was thus observed in cell types of
(neuro-)ectodermal (central nervous system, epi-
dermis, and skin-derived organs, medulla of theEXPRESSION OF GATA-3 9
adrenal gland) and mesodermal origin
(thymocytes, erythroid cells, kidney, and palate).
The expression of murine GATA-3 in erythroid
cells, fetal brain and kidney as described here, is
consistent with the expression pattern reported
for chicken GATA-3 (Yamamoto et al., 1990).
At first glance, the complex expression pattern
of GATA-3 appears to be at variance with an
important role for this gene in T-cell differen-
tiation. However, it is a common finding that
putative tissue-specific transcription factors dis-
play a wider tissue distribution than the struc-
tural target gene originally used to identify the
factor. For example, the POU-domain genes Oct-
2 and Pit-l, which are believed to control specific
expression of genes in the B-cell lineage and in
pituitary cells, respectively, both are expressed in
the developing nervous system (Xi et al., 1989).
In addition, LF-B1 is thought to be involved in
liver-specific gene expression, but is expressed in
a wide variety of other tissues (Baumhueter et al.,
1990). It is generally assumed that the exquisite
expression of target genes is the result of the
combinatorial activity of a number of positively
and negatively acting transcription factors with
restricted tissue distributions (Johnson and
McKnight, 1989). Thus, a limited number of tran-
scription factors may be utilized in varying com-
binations to produce a large variety of target
gene expression patterns. From this, it appears
likely that GATA-3 acts in concert with
additional transcription factors to control differ-
entiation within the T-cell lineage.
Other transcription factors potentially
involved in T-cell differentiation are TCF-1, LEF-
1, and Ets-1 (Leiden, 1992). Amongst these fac-
tors, the expression of TCF-1 in the lymphoid
lineage (Oosterwegel, unpublished) most closely
correlates with that of GATA-3. TCF-1 contains
an HMG box DNA-binding domain and recog-
nizes sequence motifs in the CD3-e, TCR-o, TCR-
]/, and TCR- enhancers (Oosterwegel et al., 1991;
van de Wetering et al., 1991). The expression of
TCF-1 during mouse embryogenesis is equally
complex as that of GATA-3. However, the only
cell type that coexpresses TCF-1 and GATA-3 is
the thymocyte. Therefore, we hypothesize that a
specific combination of TCF-1 and GATA-3 is
important for proper differentiation of T-lineage
cells. Knockout experiments in the mouse germ
line will shed light on the differentiation control
properties of GATA-3. The expression data
reported here will serve as a starting point for the
evaluation of such experiments.
MATERIALS AND METHODS
Cell Lines
Cells were grown in RPMI-1640 supplemented
with 5% fetal calf serum and antibiotics. All cell
lines were of routine origin. Pro- and prethymo-
cyte cell lines were derived from day 14 fetal
thymus organ culture, and transformed with a
retroviral myc-raf oncogene construct (J2) (A.
Kruisbeek, in preparation). Prothymocytes,
34.1.E and 35.1.E, express CD2, Thyl, and the
CD3-?’ gene. They are CD4/CDS-negative and
their T-cell receptor genes are in germ-line con-
figuration. No CD3-8 or CD3-e mRNA is detect-
able. This phenotype is consistent with that
described by Palacios and Pelkonen (1988). Pre-
thymocytes, 34.1.L and 35.1.L, express CD3-,
CD3-8, and CD3-e mRNA as well as partially
rearranged TCR-] mRNA and TCR-c mRNA;
they are surface TCR/CD3 and CD4/CDS-nega-
tire. T-cell lines derived by transformation of day
17 fetal thymocytes, A1 and B2, display a mature
T-cell phenotype, including the surface
expression of the TCR/CD3 complex and CD4
and CD8. 1881 is a/-negative mutant pre-B cell
line, 38B9 represents a pro-B cell line; 40E1 pre-B
cells express t and ,5.38B9 and 40E1 are derived
from fetal liver, and 1881 is derived from adult
bone marrow by transformation with Abelson
virus (Alt et al., 1981). All other cells were
obtained from the American Type Culture Col-
lection. Briefly, EL-4 is a mature TCR-o/]/sur-
face-positive T-cell line. The phenotype of
BW5147 is similar to that of EL-4, but as a result
of the absence of CD3- mRNA, no surface
expression of the TCR/CD3 complex occurs. Ag8
and Nsl are B-lineage cell lines (non-Ig secreting
myeloma cells). NIH-3T3, 3T6, and L cells are
fibroblast cell lines.
Northern Blot Analysis
Northern blot analysis was performed according
to standard procedures. RNA was isolated by
lithium chloride/urea precipitation. For each
sample, 10/g of RNA was run on a 1.2% agarose
gel containing 6% formaldehyde. RNA was blot-10 M. OOSTERWEGEL et al.
ted onto reinforced nitrocellulsoe filters (BAS 85,
0.45/m, Schleicher and Schuell). Hybridization
mix contained 5xSSPE, 5xDenhardt, 0.1% SDS,
50% formamide, 10% dextran sulfate, and 100/
g/ml salm sperm DNA. Hybridization was per-
formed overnight at 42C. High stringency wash-
ing was performed using 0.2xSSC/0.1% SDS at
65C. Kodak X-AR5 films were exposed up to 7
days with amplifying screens at-80C.
cDNA Probes
Human GATA-3 was cloned from an HPB-ALL
T-cell cDNA library by oligo probing based on
published sequence (Leiden, 1992). Sub-
sequently, murine cDNA clones were obtained
from an EL-4 phage cDNA library under con-
ditions of low stringency using the human cDNA
clone as a probe. The identity of all cDNAs was
confirmed by sequencing. For Northern blotting,
DNA probes were labeled by random oligonucle-
otide priming (Pharmacia). For CD3-y, CD3-e,
and TCR-c, full-length cDNA inserts were used.
For GATA-3, an 800-bp fragment, extending
downstream from the HindIII site at bp 1234 (Ko
et al., 1991), was used.
In situ Hybridization
In situ hybridization was performed essentially
as described by Wilkinson et al. (1987) with
modifications introduced by Kress et al. (1990).
Briefly, dissected embryos were fixed 4 to 18 hr
in 4% paraformaldehyde, dehydrated in ethanol
and butanol, and embedded in paraffin. Embryos
were sectioned at 6 tm thickness and mounted
on 3-aminopropyl-triethoxy-silane-coated slides.
Slides were deparaffined, digested with protein-
ase K, acetylated with triethanolamine, dehy-
drated and hybridized overnight at 55C. Sub-
sequently, high stringency washing was
performed in 50% formamide/2xSSC/10mM
DTT at 65C. Slides were treated with ribonu-
clease A, rinsed in 2xSSC, 0.1xSDS, dehydrated
and dipped in Ilford emulsion G.5. After drying,
the slides were exposed for up to 10 days at 4C,
developed in Kodak D-19, and fixed with Kodak
LX-24.
RNA Probe
An antisense radiolabeled RNA probe was gener-
ated from GATA-3 cDNA subcloned in
pBluescript SK, using T7 RNA polymerase and
35S-UTP (Stratagene). The construct was lin-
earized with BglII to yield a 458-bp-labeled
probe, covering 3’ untranslated sequence. The
probe was used for hybridization at lx
105 c.p.m.//1.
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